Not yet recruiting NCT07298668

Cardiovascular Risk Factors in Middle Eastern Patients With Stroke

— Observational Stroke Low-Density-Lipoprotein-cholesterol Level Risk Factors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Stroke, Low-Density-Lipoprotein-cholesterol Level, Risk Factors. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Jordan
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Standard Modifiable Risk Factors in Middle Eastern Patients With Stroke (Jo-SMMART Study)

Overview

Stroke is a well-known a leading cause of death and disability in the Middle East. There remain many knowledge gaps in evaluating the prevalence of risk factors among patients with stroke in the Middle East. Unravelling the impact of these risk factors and controlling them can positively lower the incidence of stroke. Disparities in stroke risk factors, may well be related to ethnicity of the Middle Eastern populations , will be compared with those among stroke patients in the western literature.

Detailed description

These clinically relevant issues have not been studied extensively in the Middle East where most of the studies in atherosclerotic cardiovascular disease have focused on acute coronary syndrome more than stroke. Exploring new information on risk factors of stroke in this region that helps fill some of the knowledge gaps.

Stroke has been attributed, in the majority of cases, to the traditional four standard modifiable risk factors of hypertension, type 2 diabetes, dyslipidemia, and cigarette smoking. However, ethnicity and geography account for the interregional differences of the prevalence of risk factors in patients with stroke.

The Jo-SMMART ill evaluate risk factors in 2000 stroke patients in Jordan as a representative of the Middle Eastern population, the prevalence of those with none of the 4 risk factors and the differences in clinical profiles and demographic features on those with risk factors and those with no risk factors. Lipid profile and use of lipid lowering agents will also be evaluated, and furthermore the die0fferneces between young vs old, and men vs women stroke patients ill be addressed.

Primary outcome measures

Prevalence of hypertension in stroke patients (survey interview) [Time frame: Baseline]
Prevalence of type 2 diabetes in stroke patients (survey interview) [Time frame: BASELINE]
Prevalence of elevated serum level of low density lipoprotein cholesterol in stroke patients (survey interview) [Time frame: BASELINE]
Prevalence of current cigarette smoking in stroke patients (survey interview) [Time frame: BASELINE]
Use of lipid lowering therapy (survey interview) [Time frame: BASELINE]

Eligibility criteria

Inclusion criteria

Diagnosis of stroke upon admission to the hospital
Adult aged 18 years or older
Available lipid profile on hospital admission

Exclusion criteria

Stroke diagnosis unconfirmed
age younger than 18 years
No available lipid profile on admission

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model: Case-only

Study locations

Jordan · 1 center

Istishari Hospital — Amman

Identifiers

NCT: NCT07298668 · JOCVA1.NOV2025/2

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗